<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>OAR@UM Collection:</title>
  <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/72983" />
  <subtitle />
  <id>https://www.um.edu.mt/library/oar/handle/123456789/72983</id>
  <updated>2026-04-11T11:30:40Z</updated>
  <dc:date>2026-04-11T11:30:40Z</dc:date>
  <entry>
    <title>Cancer epigenetics and its clinical applications</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/72834" />
    <author>
      <name>Grech, Alfred</name>
    </author>
    <author>
      <name>Balzan, Michael</name>
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/72834</id>
    <updated>2021-04-05T07:17:24Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Cancer epigenetics and its clinical applications
Authors: Grech, Alfred; Balzan, Michael
Abstract: Epigenetics is defined as 'somatically inheritable changes that are not accompanied by alterations in DNA sequence'. DNA methylation, histone modifications and non-coding RNAs are all epigenetic mechanisms. Epigenetic aberrations (or epimutations) have been found to be responsible for carcinogenesis. The research of these epimutations is providing a platform for their application in cancer diagnosis, prognosis and therapeutics.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Getting to grips with SPMS</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/72833" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/72833</id>
    <updated>2021-04-05T07:17:07Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Getting to grips with SPMS
Abstract: DR JOSANNE AQUILINA discusses the management of&#xD;
Secondary Progressive Multiple Sclerosis with DR IAN ELLUL.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The Synapse : the Medical Professionals' Network : volume 19 : issue 5</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/72830" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/72830</id>
    <updated>2021-04-05T07:16:08Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: The Synapse : the Medical Professionals' Network : volume 19 : issue 5
Editors: Galea, Wilfred; Ellul, Ian C.
Abstract: Table of contents:; 1/ ELLUL, I. C. - Vaccination : quo vadis?; 2/ ELLUL, I. C., AQUILINA, J. - Getting to grips with SPMS; 3/ CILIA-VINCENTI, A. - Can bronchial carcinoma be ascribed to asbestos exposure for industrial disease compensation purposes?; 4/ GRECH, A., &amp; BALZAN, M. - Cancer epigenetics and its clinical applications; 5/ CAUCHI, M. - Doctors for the Environment Malta; 6/ CAMILLERI, M. - Smoking in the 21st century; 7/ FALZON, S., COLLICT, M., &amp; SALIBA, I. - Cervical cancer : the importance of screening and vaccination; 8/ VASSALLO, P. - Imaging back pain : part 2</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Vaccination : quo vadis?</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/72829" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/72829</id>
    <updated>2021-04-05T07:15:55Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Vaccination : quo vadis?
Abstract: Evidence has it that the multi-organ effect of Sars-CoV-2 is primarily attributed to hypercytokinemia, especially in the elderly &amp; immunocompromised. Malta has suffered the brunt of this. According to the European Centre for Disease Prevention and Control, as of 30 September 2020, the 14-day cumulative number of Covid-19 deaths per 100,000 was 3.6 for Malta, topping the EU/EEA charts. If Covid-19 excess deaths were factored in, Malta would possibly fare better; nonetheless Malta is facing a serious problem stemming from the ingrained laissez-faire attitude of the general public. [excerpt]</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

